Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitetheravectys.com
CategoryBioTech
Phone33-1-44-38-93-13
Employees
Founded2005

Offices

Paris, FRA
Bâtiment Pasteur Biotop
28 rue du Docteur Roux
Paris, 75015, FRA

People

CEO
Non-Executive Director

Funding

TOTAL $28.3M
FUNDING TOTAL $28.3M
Series C, 9/2012
Guy PAILLAUD
John PIETERS
Philippe ODDO
Richard HENNESSY
€7.48M
Series D, 10/2013
Tethys BioScience
€14.7M

Tags

THERAVECTYS

THERAVECTYS is a development-stage biotechnology company with a novel vaccine platform that can be applied to the treatment and prevention of a broad range of infectious diseases, cancers, and other diseases and conditions. Their first clinical studies will be in HIV/AIDS, using their lead product, a therapeutic vaccine, which has shown promising efficacy and safety in non-human primates.

Recent Milestones

Videos

Screenshots

THERAVECTYS screenshot
Above: THERAVECTYS
Uploaded: 9/4/12

Sources

  1. THERAVECTYS Raises €7.48 millon (in.finance.yahoo.com) [edit]
  2. Theravectys Raises €14.7M (finsmes.com) [edit]
Edit This Page
Last Edited 12/28/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy